Vanguard Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-91,023
| Closed | -$406K | – | 4365 |
|
|
2024
Q3 | $406K | Sell |
91,023
-2
| -0% | -$13 | ﹤0.01% | 4025 |
|
|
2024
Q2 | $546K | Sell |
91,025
-1,486
| -2% | -$7.8K | ﹤0.01% | 3976 |
|
|
2024
Q1 | $760K | Buy |
92,511
+30
| +0% | +$160 | ﹤0.01% | 3898 |
|
|
2023
Q4 | $463K | Hold |
92,481
| – | – | ﹤0.01% | 4058 |
|
|
2023
Q3 | $573K | Hold |
92,481
| – | – | ﹤0.01% | 4019 |
|
|
2023
Q2 | $1.29M | Hold |
92,481
| – | – | ﹤0.01% | 3821 |
|
|
2023
Q1 | $1.09M | Hold |
92,481
| – | – | ﹤0.01% | 3887 |
|
|
2022
Q4 | $1.8M | Buy |
92,481
+46
| +0% | +$783 | ﹤0.01% | 3703 |
|
|
2022
Q3 | $1.31M | Hold |
92,435
| – | – | ﹤0.01% | 3913 |
|
|
2022
Q2 | $2.24M | Hold |
92,435
| – | – | ﹤0.01% | 3760 |
|
|
2022
Q1 | $3.21M | Sell |
92,435
-366
| -0.4% | -$11.1K | ﹤0.01% | 3747 |
|
|
2021
Q4 | $2.67M | Sell |
92,801
-132
| -0.1% | -$5.17K | ﹤0.01% | 3932 |
|
|
2021
Q3 | $4.6M | Hold |
92,933
| – | – | ﹤0.01% | 3716 |
|
|
2021
Q2 | $4.71M | Sell |
92,933
-17,394
| -16% | -$876K | ﹤0.01% | 3640 |
|
|
2021
Q1 | $6.32M | Buy |
110,327
+14,494
| +15% | +$944K | ﹤0.01% | 3404 |
|
|
2020
Q4 | $4.31M | Buy |
95,833
+815
| +0.9% | +$39.3K | ﹤0.01% | 3426 |
|
|
2020
Q3 | $4.79M | Sell |
95,018
-132
| -0.1% | -$7.16K | ﹤0.01% | 3174 |
|
|
2020
Q2 | $5.79M | Buy |
95,150
+39,243
| +70% | +$2.37M | ﹤0.01% | 3033 |
|
|
2020
Q1 | $2.12M | Buy |
55,907
+1,255
| +2% | +$54.8K | ﹤0.01% | 3289 |
|
|
2019
Q4 | $2.55M | Hold |
54,652
| – | – | ﹤0.01% | 3378 |
|
|
2019
Q3 | $2.37M | Buy |
54,652
+23,127
| +73% | +$1.03M | ﹤0.01% | 3396 |
|
|
2019
Q2 | $1.4M | Buy |
31,525
+980
| +3% | +$44.2K | ﹤0.01% | 3577 |
|
|
2019
Q1 | $1.63M | Buy |
30,545
+2,669
| +10% | +$133K | ﹤0.01% | 3511 |
|
|
2018
Q4 | $1.3M | Buy |
27,876
+4,244
| +18% | +$244K | ﹤0.01% | 3486 |
|
|
2018
Q3 | $1.31M | Buy |
23,632
+9,150
| +63% | +$619K | ﹤0.01% | 3653 |
|
|
2018
Q2 | $1.25M | Buy |
+14,482
| New | +$1.35M | ﹤0.01% | 3630 |
|
Vanguard Group's ORGS Position: Q4 2024 in Review
Vanguard Group sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 91,023 shares — an estimated $406K sold.
Vanguard Group first reported a position in ORGS in Q2 2018 and held it in 26 quarters. The position peaked at $6.32M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.
- Vanguard Group reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Vanguard Group sold 91,023 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $406K.
- Vanguard Group first reported a position in Orgenesis Inc. Common Stock in Q2 2018 and held it in 26 quarters.
- Vanguard Group's Orgenesis Inc. Common Stock position peaked at $6.32M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.
Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.